Profusa and Partners Announce Initiation of Study to Measure Early Signs of Influenza Through Biosensor Technology

DARPA-Backed Study Leverages Profusa’s Lumee® Oxygen Platform as Part of a Larger Effort to Speed Detection and Predict Disease Outbreaks EMERYVILLE, Calif., March 3, 2020 – Profusa, a digital health company that is pioneering the next generation of personalized medicine, today announced the initiation of a study that will use the Company’s minimally invasive injectable […] The post Profusa and Partners Announce Initiation of Study to Measure Early Signs of Influenza Through Biosensor Technology appeared first on Profusa, Inc. .